HTGM
HTG Molecular Diagnostics Inc
-37.26%
$4.67 - $2.93
Feb 7th 2023 - Mar 21st 2023
Jan, 13, 2023
$HTGM is over 100% since yesterday, looks for a go... See more
Dec, 27, 2022
Plus it is expecting more positive catalysts in we... See more
MMAT
Meta Materials Inc
-39.04%
$0.94 - $0.57
Feb 7th 2023 - Mar 21st 2023
Nov, 17, 2022
$MMTLP $MMAT Signs of approval coming.
Nov, 10, 2022
$MMAT Though the entire market was green only bein... See more
Jan, 13, 2023
$HTGM is over 100% since yesterday, looks for a good entry $KERN had a lot of volume yesterday $1.5 can be a good entry $VYNE announce split has been approved by board and can be executed at any time
Dec, 27, 2022
Plus it is expecting more positive catalysts in weeks and months: 5 year data for breast cancer, Canada approval, China commercialziation, and much more.
Dec, 14, 2022
FDA approved.
Mar, 13, 2023
gets a drug approved and immediately rewards shareholders!!!
Feb, 22, 2023
$PRVB 8.60 to 8.80 has been good support since approval.
Feb, 18, 2023
If that gets approved its 10.000 times better than Provention Bio.
Feb, 6, 2023
Great to see the FDA approval, as well as $SNY commitment.
Nov, 25, 2022
$PRVB While reaching this milestone of approval has been inspirational, it is now the aspirational goal of population screening which is at the forefront.
Nov, 22, 2022
It works, there is a need for it, there is insurance buy in on it, there is a global sales team, there is further label expansion and approvals in the future, and there are additional drugs in the pipeline from this company that show the same promise.
Nov, 21, 2022
PRVB is in a MUCH better financial situation now with FDA approval giving them a multi-billion USD asset (Teplizumab) which they can get conventional financing from A BANK!!
Nov, 21, 2022
It's APPROVED !!
Nov, 18, 2022
$PRVB Interesting they received approval which is good.
Nov, 18, 2022
$PRVB good that they have got an approval.
Nov, 17, 2022
$MMTLP $MMAT Signs of approval coming.
Nov, 10, 2022
$MMAT Though the entire market was green only being down 5% after a 100% run up is not bad at all especially when that run was based off hype and speculation that the s1 would be approved last night.
Nov, 7, 2022
$mmtlp $MMAT regaining compliance followed by an S1 approval later on, I think yes ๐
Nov, 7, 2022
$MMAT healthy af ready for next leg up right in time for compliance and $MMTLP S1 approval
Nov, 7, 2022
(Anticipated) S1A approval and record date announced is bullish.
Nov, 3, 2022
approval would time quite nicely with the new HQ opening.
Oct, 31, 2022
$MMAT 14 Reviews on Glassdoor 91% CEO approval, 93% recommend employment.
Oct, 28, 2022
Happy with where I stand and after almost 2 years of being here I can safely say I am ready for the next few weeks leading up to the S1 approval and facility opening on the 17th.
Oct, 26, 2022
$mmat $mmtlp S1 approval ๐ค
Oct, 21, 2022
$MMAT s1 approved!!!!! !